Skip to main content
. 2019 Dec 17;33(4):803–816. doi: 10.1007/s40620-019-00686-z

Table 3.

Baseline predictors of time to first hypocalcemia episode in the first 12 months after cinacalcet initiation

Characteristics Any hypocalcemia vs no hypocalcemia
No. of hypocalcemia events/total no. of subjects (%) Hazard ratio (95% CI) p value
Geographical area 0.01
 Iberian Peninsulaa 513/750 (68.4) References
 Eastern Europeb 56/81 (69.1) 1.22 (0.87, 1.70)
 Western Europec 41/74 (55.4) 0.65 (0.46, 0.90)
Catheter vascular access <0.001
 No 434/680 (63.8) References
 Yes 158/195 (81.0) 1.59 (1.32, 1.92)
 Missing information 18/30 (60.0) 0.91 (0.52, 1.57)
Haemoglobin [g/dL] 0.03
  ≥ 12 306/436 (70.2) References
 10–< 12 276/423 (65.2) 0.87 (0.74, 1.03)
  < 10 28/46 (60.9) 0.61 (0.41, 0.91)
Serum albumin [g/L] 0.003
 Q4 98/160 (61.3) References
 Q3 155/258 (60.1) 1.07 (0.83, 1.37)
 Q2 167/222 (75.2) 1.46 (1.13, 1.87)
 Q1 156/213 (73.2) 1.47 (1.14, 1.91)
 Missing data 34/52 (65.4) 1.25 (0.84, 1.85)
PTH [pg/mL] 0.005
  < 600 303/476 (63.7) References
 600–< 1000 206/283 (72.8) 1.32 (1.11, 1.58)
  ≥ 1000 101/146 (69.2) 1.26 (0.99, 1.60)

Q quartile

aEastern Europe: Czech Republic, Hungary, Poland, Romania, Russia, Serbia, Slovak Republic, Slovenia and Turkey

bWestern Europe: France, Ireland, Italy, and the United Kingdom

cIberian Peninsula: Portugal and Spain